![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/155 | |
A61K 31/343 | |||
A61K 31/36 | |||
A61K 31/381 | |||
A61K 31/40 | |||
A61K 31/341 | |||
A61K 31/41 | |||
A61K 31/53 | |||
A61P 3/00 |
(11) | Number of the document | 2800561 |
(13) | Kind of document | T |
(96) | European patent application number | 12738330.5 |
Date of filing the European patent application | 2012-07-11 | |
(97) | Date of publication of the European application | 2014-11-12 |
(45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/046335 |
Date | 2012-07-11 |
(87) | Number | WO 2013/103384 |
Date | 2013-07-11 |
(30) | Number | Date | Country code |
PCT/US2012/0205 | 2012-01-06 | WO | |
201213345135 | 2012-01-06 | US | |
201261649171 P | 2012-05-18 | US |
(72) |
BARON, Alain, D., US
FINEMAN, Mark, S., US
BEELEY, Nigel, R. A., US
|
(73) |
Anji Pharma (US) LLC,
4 Dana Road, Boxford, MA 01921,
US
|
(54) | BIGUANIDE COMPOSITIONS AND METHODS OF TREATING METABOLIC DISORDERS |
BIGUANIDE COMPOSITIONS AND METHODS OF TREATING METABOLIC DISORDERS |